Unlocking the Potential of Drug Design with a New Tool for Efficiently Measuring Ligand Affinity
A new tool has been developed to more efficiently measure the affinity of ligands to proteins, a key factor in drug discovery. This breakthrough was developed by an international team of researchers led by Dr. Paul R. Thompson at the University of Manchester. The tool, known as LAFF, is able to measure the affinity of ligands to proteins in a fraction of the time that it would take to use traditional methods. The new tool has the potential to revolutionize drug discovery by allowing researchers to quickly and accurately evaluate potential drugs. This could speed up the development of new drugs and improve their effectiveness.
source: Phys.org